Chromosome gain is frequent in acute myeloid leukemia (AML) and is counted alongside structural abnormalities when determining karyotype complexity. However, there are few studies investigating the ...
As the era of the blockbuster drug is fading, the pharmaceutical industry is more heavily leaning on the promise of personalized medicine (often called tailored therapeutics, precision medicine or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results